Medicine Man Technologies Inc (SHWZ)

[In Plain Sight]

Some light reading on the last trading day of 2022. I like SHWZ (especially as to numbers 3, 7, 8, and 9) here as organized the frontloading for viability well ahead of the crowd and articulated by JD on numerous occasions.

Well, well, well. The knives come out. Not that we haven't discussed this enumerated thesis in detail for the last year and avoided the worst that are still on top 50 lists like MMNNF, RWBYF, TILTF, STHZ, and ITHUF. What is funny is the protracted pump of the Tier I's is deflating as Kass points to here and the redemption cycle for ETFs will maintain downward pressure for the foreseeable future (MSOS's itchy fingers and alike):

Nine reasons why I would not bottom fish cannabis stocks right now (by @DougKass) $MSOS pic.twitter.com/GmKTOB9OEu

— WeedStreet420 (@WeedStreet420) December 29, 2022

Kass also goes on to essentially call Cantor's newly revised downward price targets unrealistic for Tier I's like CURLF and CRLBF. Reality sucks? That's so dope:

This morning Cantor reduces price targets in Curaleaf and Cresco Labs (cannabis) from $13 to $12 and from $15 to $14.25. $CURLF last sale $4.08, $CRBLF $1.84.
Then look at his price targets earlier this year...
To put it mildly, don't believe the hype. https://t.co/nmzAP4A9f0

— Dougie Kass (@DougKass) December 30, 2022